|
Market Closed -
Bombay S.E.
03:32:27 03/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 8.750 INR | +6.58% |
|
-1.46% | -38.81% |
| 01/10 | Gennex Laboratories Limited Announces Board Changes | CI |
| 14/08 | Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 212.58Cr 2.24Cr 2Cr 1.84Cr 1.67Cr 3.14Cr 3.22Cr 22Cr 8.84Cr 112.2Cr 8.42Cr 8.24Cr 355.62Cr | P/E 2025 |
15.4x | P/E 2026 | 8.26x |
|---|---|---|---|---|---|
| Enterprise Value | 254.53Cr 2.69Cr 2.4Cr 2.21Cr 2Cr 3.76Cr 3.86Cr 26Cr 11Cr 134.34Cr 10Cr 9.87Cr 425.8Cr | EV / Sales 2025 |
1.79x | EV / Sales 2026 | 1.25x |
| Free-Float |
66.61% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +6.58% | ||
| 1 week | -1.46% | ||
| Current month | +9.10% | ||
| 1 month | -10.71% | ||
| 3 months | -3.31% | ||
| 6 months | -12.41% | ||
| Current year | -38.81% |
| 1 week | 7.7 | 9.2 | |
| 1 month | 7.7 | 10.25 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 16.3 | |
| 3 years | 7.05 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 18/05/2012 |
| Director of Finance/CFO | - | 12/11/2024 | |
| Compliance Officer | 62 | 20/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 21/12/2020 | |
| Director/Board Member | 62 | 01/10/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.58% | -1.46% | -43.40% | -22.29% | 2.11Cr | ||
| -0.11% | +9.94% | +57.20% | +148.21% | 1,25700Cr | ||
| -1.62% | -0.95% | +42.90% | +75.88% | 65TCr | ||
| -0.98% | -0.14% | +34.93% | +102.23% | 51TCr | ||
| -1.56% | -1.39% | +51.02% | +64.18% | 39TCr | ||
| -2.49% | +2.01% | +75.38% | +39.94% | 37TCr | ||
| -0.02% | +3.15% | +32.47% | +55.33% | 30TCr | ||
| -0.72% | +7.32% | +11.29% | +33.98% | 29TCr | ||
| -0.90% | +2.97% | +55.67% | +70.93% | 25TCr | ||
| -1.68% | +5.27% | +37.21% | +105.26% | 21TCr | ||
| Average | -0.35% | +2.53% | +35.47% | +67.36% | 42.27TCr | |
| Weighted average by Cap. | -0.95% | +4.15% | +47.32% | +93.23% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 137.9Cr 1.46Cr 1.3Cr 1.19Cr 1.09Cr 2.04Cr 2.09Cr 14Cr 5.74Cr 73Cr 5.46Cr 5.35Cr 230.7Cr | 172.74Cr 1.82Cr 1.63Cr 1.5Cr 1.36Cr 2.55Cr 2.62Cr 18Cr 7.19Cr 91Cr 6.84Cr 6.7Cr 288.98Cr |
| Net income | 18Cr 19.13L 17.09L 15.7L 14.26L 26.78L 27.45L 1.87Cr 75.39L 9.57Cr 71.81L 70.27L 30Cr | 21Cr 22.15L 19.79L 18.17L 16.51L 31L 31.78L 2.17Cr 87.27L 11Cr 83.13L 81.35L 35Cr |
| Net Debt | -27Cr -29.01L -25.91L -23.8L -21.62L -40.6L -41.62L -2.84Cr -1.14Cr -15Cr -1.09Cr -1.07Cr -46Cr | 42Cr 44.28L 39.56L 36.34L 33.01L 61.98L 63.54L 4.34Cr 1.75Cr 22Cr 1.66Cr 1.63Cr 70Cr |
Employees
125
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | ₹8.750 | +6.58% | 3,21,525 |
| 02/26/02 | ₹8.210 | +2.37% | 10,53,207 |
| 30/26/30 | ₹8.020 | -10.49% | 13,21,688 |
| 29/26/29 | ₹8.960 | -1.54% | 1,88,622 |
| 28/26/28 | ₹9.100 | +2.48% | 2,86,354 |
- Stock Market
- Stocks
- 531739 Stock
Select your edition
All financial news and data tailored to specific country editions
















